Literature DB >> 16731507

Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity.

Andre L Samson1, Robert L Medcalf.   

Abstract

For over a decade, tissue-type plasminogen activator (t-PA), a serine protease classically known for its profibrinolytic role in the vasculature, has been implicated in numerous aspects of the synaptic plasticity process. But despite being the most intensively studied protease of the CNS, the mechanisms and molecular mediators behind the action of t-PA on synaptic efficacy remain largely undefined. Rather than examine the role of t-PA in proteolytic remodeling of the synaptic extracellular matrix, this review will focus on the evidence that defines t-PA as a direct modulator of neurotransmission and synaptic plasticity by impacting on glutamatergic and dopaminergic pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731507     DOI: 10.1016/j.neuron.2006.04.013

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  74 in total

1.  Ventral striatal plasticity and spatial memory.

Authors:  Valentina Ferretti; Pascal Roullet; Francesca Sargolini; Arianna Rinaldi; Valentina Perri; Martina Del Fabbro; Vivian J A Costantini; Valentina Annese; Gianluigi Scesa; Maria Egle De Stefano; Alberto Oliverio; Andrea Mele
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

2.  Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence.

Authors:  David J Elzi; Yanlai Lai; Meihua Song; Kevin Hakala; Susan T Weintraub; Yuzuru Shiio
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

Review 3.  Hypertension and cerebrovascular dysfunction.

Authors:  Costantino Iadecola; Robin L Davisson
Journal:  Cell Metab       Date:  2008-06       Impact factor: 27.287

4.  Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function.

Authors:  Andre L Samson; Simon T Nevin; David Croucher; Be'eri Niego; Philip B Daniel; Thomas W Weiss; Eliza Moreno; Denis Monard; Daniel A Lawrence; Robert L Medcalf
Journal:  J Neurochem       Date:  2008-09-15       Impact factor: 5.372

5.  No evidence for an association between genetic variation at the SERPINI1 locus and ischemic stroke.

Authors:  A Tjärnlund-Wolf; S Olsson; K Jood; C Blomstrand; C Jern
Journal:  J Neurol       Date:  2011-04-13       Impact factor: 4.849

6.  Complement-Dependent Synaptic Uptake and Cognitive Decline after Stroke and Reperfusion Therapy.

Authors:  Ali M Alawieh; E Farris Langley; Wuwei Feng; Alejandro M Spiotta; Stephen Tomlinson
Journal:  J Neurosci       Date:  2020-04-14       Impact factor: 6.167

7.  Tissue-type plasminogen activator protects neurons from excitotoxin-induced cell death via activation of the ERK1/2-CREB-ATF3 signaling pathway.

Authors:  Fang Wu; Ramiro Echeverry; Jialing Wu; Jie An; Woldeab B Haile; Deborah S Cooper; Marcela Catano; Manuel Yepes
Journal:  Mol Cell Neurosci       Date:  2012-10-09       Impact factor: 4.314

8.  Tissue plasminogen activator modulates the cellular and behavioral response to cocaine.

Authors:  Rajani Maiya; Yan Zhou; Erin H Norris; Mary Jeanne Kreek; Sidney Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-30       Impact factor: 11.205

Review 9.  Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.

Authors:  Rao Muralikrishna Adibhatla; James F Hatcher
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

10.  Increasing tPA activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouse.

Authors:  Hongqi Xin; Yi Li; Li Hong Shen; Xianshuang Liu; Xinli Wang; Jing Zhang; Siamak Pourabdollah-Nejad D; Chunling Zhang; Li Zhang; Hao Jiang; Zheng Gang Zhang; Michael Chopp
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.